Effectively Communicating Pipeline Information to Drive Payers Attention
By Xcenda
As payers are conducting product reviews for budgetary planning and formulary decision-making, they are increasingly looking for information—data and evidence—earlier in their process, before regulatory approval. What pre-approval information are payers looking for and when do they need it? What resources are available to both payers and manufacturers to help facilitate this information exchange? Xcenda explored these topics at a recent presentation at AMCP Nexus 2019.
AMCP Nexus 2019 | FORMULARYDECISIONS MANUFACTURER FOCUS GROUP
Effectively Communicating Pipeline Information to Drive Payers’ Attention
As payers are conducting product reviews for budgetary planning and formulary decision-making, they are increasingly looking for information—data and evidence—earlier in their process, before regulatory approval.
What pre-approval information are payers looking for and when do they need it? What resources are available to both payers and manufacturers to help facilitate this information exchange?
Xcenda explored these questions at a recent presentation at AMCP Nexus 2019 where they provided clarity on:
- The payer perspective and their current pre-approval needs
- What payers are using as an active resource for pre-approval product reviews
- The manufacturers' role in pre-approval information exchange
